This pipeline computes the correlation between cancer subtypes identified by different molecular patterns and selected clinical features.
Testing the association between subtypes identified by 10 different clustering approaches and 9 clinical features across 166 patients, 15 significant findings detected with P value < 0.05.
-
CNMF clustering analysis on array-based mRNA expression data identified 3 subtypes that do not correlate to any clinical features.
-
Consensus hierarchical clustering analysis on array-based mRNA expression data identified 3 subtypes that correlate to 'Time to Death'.
-
5 subtypes identified in current cancer cohort by 'CN CNMF'. These subtypes correlate to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
3 subtypes identified in current cancer cohort by 'METHLYATION CNMF'. These subtypes correlate to 'TUMOR.STAGE'.
-
CNMF clustering analysis on RPPA data identified 3 subtypes that correlate to 'GENDER' and 'PATHOLOGICSPREAD(M)'.
-
Consensus hierarchical clustering analysis on RPPA data identified 5 subtypes that correlate to 'Time to Death', 'AGE', and 'PATHOLOGICSPREAD(M)'.
-
CNMF clustering analysis on sequencing-based mRNA expression data identified 4 subtypes that correlate to 'HISTOLOGICAL.TYPE'.
-
Consensus hierarchical clustering analysis on sequencing-based mRNA expression data identified 3 subtypes that correlate to 'HISTOLOGICAL.TYPE'.
-
CNMF clustering analysis on sequencing-based miR expression data identified 5 subtypes that correlate to 'PATHOLOGY.N' and 'PATHOLOGICSPREAD(M)'.
-
Consensus hierarchical clustering analysis on sequencing-based miR expression data identified 3 subtypes that correlate to 'HISTOLOGICAL.TYPE' and 'PATHOLOGICSPREAD(M)'.
Clinical Features |
Time to Death |
AGE | GENDER |
HISTOLOGICAL TYPE |
PATHOLOGY T |
PATHOLOGY N |
PATHOLOGICSPREAD(M) |
TUMOR STAGE |
RADIATIONS RADIATION REGIMENINDICATION |
Statistical Tests | logrank test | ANOVA | Fisher's exact test | Fisher's exact test | Chi-square test | Chi-square test | Chi-square test | Chi-square test | Fisher's exact test |
mRNA CNMF subtypes | 0.274 | 0.499 | 0.953 | 0.365 | 0.0987 | 0.66 | 0.407 | 0.639 | 0.29 |
mRNA cHierClus subtypes | 0.0075 | 0.394 | 0.865 | 0.692 | 0.245 | 0.574 | 0.212 | 0.504 | 1 |
CN CNMF | 0.00743 | 0.373 | 0.568 | 0.0316 | 0.564 | 0.104 | 0.0929 | 0.477 | 0.238 |
METHLYATION CNMF | 0.58 | 0.291 | 0.494 | 0.274 | 0.524 | 0.708 | 0.261 | 0.0317 | 0.857 |
RPPA CNMF subtypes | 0.904 | 0.513 | 0.0423 | 0.255 | 0.2 | 0.114 | 0.0137 | 0.157 | 1 |
RPPA cHierClus subtypes | 0.0032 | 0.0282 | 0.378 | 0.157 | 0.402 | 0.0918 | 0.0124 | 0.218 | 0.785 |
RNAseq CNMF subtypes | 0.66 | 0.478 | 0.586 | 0.00271 | 0.143 | 0.702 | 0.696 | 0.562 | 0.472 |
RNAseq cHierClus subtypes | 0.382 | 0.283 | 0.87 | 2.93e-05 | 0.709 | 0.761 | 0.589 | 0.842 | 0.569 |
MIRseq CNMF subtypes | 0.314 | 0.892 | 0.461 | 0.313 | 0.251 | 0.0172 | 0.0461 | 0.117 | 0.283 |
MIRseq cHierClus subtypes | 0.774 | 0.582 | 0.973 | 0.037 | 0.726 | 0.244 | 0.000442 | 0.361 | 0.298 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 25 | 20 | 24 |
P value = 0.274 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 39 | 4 | 0.9 - 52.0 (6.0) |
subtype1 | 20 | 1 | 0.9 - 49.9 (13.3) |
subtype2 | 7 | 0 | 1.0 - 12.7 (1.0) |
subtype3 | 12 | 3 | 1.0 - 52.0 (1.5) |
P value = 0.499 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 69 | 66.6 (10.7) |
subtype1 | 25 | 64.6 (12.3) |
subtype2 | 20 | 67.9 (9.9) |
subtype3 | 24 | 67.7 (9.5) |
P value = 0.953 (Fisher's exact test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 31 | 38 |
subtype1 | 12 | 13 |
subtype2 | 9 | 11 |
subtype3 | 10 | 14 |
P value = 0.365 (Fisher's exact test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 58 | 7 |
subtype1 | 19 | 3 |
subtype2 | 16 | 3 |
subtype3 | 23 | 1 |
P value = 0.0987 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 5 | 15 | 45 | 4 |
subtype1 | 3 | 6 | 16 | 0 |
subtype2 | 2 | 5 | 13 | 0 |
subtype3 | 0 | 4 | 16 | 4 |
P value = 0.66 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 42 | 15 | 12 |
subtype1 | 16 | 5 | 4 |
subtype2 | 14 | 4 | 2 |
subtype3 | 12 | 6 | 6 |
P value = 0.407 (Fisher's exact test)
nPatients | M0 | M1 |
---|---|---|
ALL | 57 | 12 |
subtype1 | 21 | 4 |
subtype2 | 18 | 2 |
subtype3 | 18 | 6 |
P value = 0.639 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 18 | 23 | 16 | 10 |
subtype1 | 8 | 8 | 5 | 3 |
subtype2 | 7 | 7 | 4 | 2 |
subtype3 | 3 | 8 | 7 | 5 |
P value = 0.29 (Fisher's exact test)
nPatients | NO | YES |
---|---|---|
ALL | 1 | 68 |
subtype1 | 0 | 25 |
subtype2 | 1 | 19 |
subtype3 | 0 | 24 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 19 | 24 | 26 |
P value = 0.0075 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 39 | 4 | 0.9 - 52.0 (6.0) |
subtype1 | 10 | 2 | 1.0 - 38.0 (1.0) |
subtype2 | 20 | 2 | 0.9 - 52.0 (13.7) |
subtype3 | 9 | 0 | 1.0 - 17.0 (1.0) |
P value = 0.394 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 69 | 66.6 (10.7) |
subtype1 | 19 | 68.4 (8.7) |
subtype2 | 24 | 64.2 (12.8) |
subtype3 | 26 | 67.5 (9.7) |
P value = 0.865 (Fisher's exact test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 31 | 38 |
subtype1 | 8 | 11 |
subtype2 | 12 | 12 |
subtype3 | 11 | 15 |
P value = 0.692 (Fisher's exact test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 58 | 7 |
subtype1 | 18 | 1 |
subtype2 | 19 | 3 |
subtype3 | 21 | 3 |
P value = 0.245 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 5 | 15 | 45 | 4 |
subtype1 | 0 | 3 | 13 | 3 |
subtype2 | 3 | 6 | 14 | 1 |
subtype3 | 2 | 6 | 18 | 0 |
P value = 0.574 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 42 | 15 | 12 |
subtype1 | 9 | 6 | 4 |
subtype2 | 15 | 4 | 5 |
subtype3 | 18 | 5 | 3 |
P value = 0.212 (Fisher's exact test)
nPatients | M0 | M1 |
---|---|---|
ALL | 57 | 12 |
subtype1 | 14 | 5 |
subtype2 | 19 | 5 |
subtype3 | 24 | 2 |
P value = 0.504 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 18 | 23 | 16 | 10 |
subtype1 | 2 | 6 | 6 | 4 |
subtype2 | 8 | 7 | 4 | 4 |
subtype3 | 8 | 10 | 6 | 2 |
P value = 1 (Fisher's exact test)
nPatients | NO | YES |
---|---|---|
ALL | 1 | 68 |
subtype1 | 0 | 19 |
subtype2 | 0 | 24 |
subtype3 | 1 | 25 |
Cluster Labels | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Number of samples | 7 | 32 | 46 | 55 | 22 |
P value = 0.00743 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 125 | 11 | 0.2 - 121.1 (6.3) |
subtype1 | 7 | 0 | 0.4 - 121.1 (9.4) |
subtype2 | 24 | 4 | 1.0 - 51.5 (5.0) |
subtype3 | 31 | 3 | 0.5 - 119.5 (6.3) |
subtype4 | 46 | 1 | 0.2 - 70.0 (4.7) |
subtype5 | 17 | 3 | 0.8 - 38.9 (13.0) |
P value = 0.373 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 162 | 64.7 (11.8) |
subtype1 | 7 | 61.9 (9.9) |
subtype2 | 32 | 64.4 (11.8) |
subtype3 | 46 | 66.4 (12.5) |
subtype4 | 55 | 62.7 (11.9) |
subtype5 | 22 | 67.5 (10.3) |
P value = 0.568 (Chi-square test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 74 | 88 |
subtype1 | 1 | 6 |
subtype2 | 15 | 17 |
subtype3 | 22 | 24 |
subtype4 | 26 | 29 |
subtype5 | 10 | 12 |
P value = 0.0316 (Chi-square test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 143 | 13 |
subtype1 | 7 | 0 |
subtype2 | 32 | 0 |
subtype3 | 40 | 4 |
subtype4 | 44 | 9 |
subtype5 | 20 | 0 |
P value = 0.564 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 9 | 29 | 109 | 14 |
subtype1 | 1 | 0 | 5 | 1 |
subtype2 | 1 | 4 | 23 | 3 |
subtype3 | 1 | 8 | 31 | 6 |
subtype4 | 5 | 14 | 34 | 2 |
subtype5 | 1 | 3 | 16 | 2 |
P value = 0.104 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 83 | 45 | 32 |
subtype1 | 5 | 0 | 2 |
subtype2 | 14 | 12 | 5 |
subtype3 | 23 | 11 | 11 |
subtype4 | 34 | 15 | 6 |
subtype5 | 7 | 7 | 8 |
P value = 0.0929 (Chi-square test)
nPatients | M0 | M1 | M1A | MX |
---|---|---|---|---|
ALL | 123 | 22 | 2 | 13 |
subtype1 | 7 | 0 | 0 | 0 |
subtype2 | 22 | 9 | 0 | 0 |
subtype3 | 34 | 7 | 0 | 5 |
subtype4 | 45 | 4 | 1 | 4 |
subtype5 | 15 | 2 | 1 | 4 |
P value = 0.477 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 30 | 50 | 50 | 25 |
subtype1 | 1 | 4 | 2 | 0 |
subtype2 | 4 | 9 | 9 | 7 |
subtype3 | 6 | 17 | 13 | 7 |
subtype4 | 16 | 15 | 16 | 7 |
subtype5 | 3 | 5 | 10 | 4 |
P value = 0.238 (Chi-square test)
nPatients | NO | YES |
---|---|---|
ALL | 6 | 156 |
subtype1 | 1 | 6 |
subtype2 | 0 | 32 |
subtype3 | 1 | 45 |
subtype4 | 2 | 53 |
subtype5 | 2 | 20 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 27 | 38 | 30 |
P value = 0.58 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 88 | 8 | 0.2 - 121.1 (6.2) |
subtype1 | 27 | 2 | 0.2 - 121.1 (6.9) |
subtype2 | 35 | 3 | 0.2 - 60.0 (7.4) |
subtype3 | 26 | 3 | 0.3 - 72.1 (3.0) |
P value = 0.291 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 95 | 63.3 (12.3) |
subtype1 | 27 | 60.3 (9.4) |
subtype2 | 38 | 63.9 (12.8) |
subtype3 | 30 | 65.3 (13.6) |
P value = 0.494 (Fisher's exact test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 42 | 53 |
subtype1 | 11 | 16 |
subtype2 | 15 | 23 |
subtype3 | 16 | 14 |
P value = 0.274 (Fisher's exact test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 87 | 6 |
subtype1 | 26 | 1 |
subtype2 | 35 | 1 |
subtype3 | 26 | 4 |
P value = 0.524 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 4 | 13 | 66 | 11 |
subtype1 | 2 | 4 | 18 | 3 |
subtype2 | 1 | 7 | 23 | 6 |
subtype3 | 1 | 2 | 25 | 2 |
P value = 0.708 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 41 | 30 | 21 |
subtype1 | 12 | 8 | 6 |
subtype2 | 14 | 15 | 8 |
subtype3 | 15 | 7 | 7 |
P value = 0.261 (Chi-square test)
nPatients | M0 | M1 | M1A | MX |
---|---|---|---|---|
ALL | 67 | 10 | 2 | 14 |
subtype1 | 17 | 6 | 1 | 3 |
subtype2 | 27 | 1 | 1 | 7 |
subtype3 | 23 | 3 | 0 | 4 |
P value = 0.0317 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 11 | 28 | 35 | 15 |
subtype1 | 5 | 7 | 7 | 7 |
subtype2 | 5 | 7 | 19 | 3 |
subtype3 | 1 | 14 | 9 | 5 |
P value = 0.857 (Fisher's exact test)
nPatients | NO | YES |
---|---|---|
ALL | 5 | 90 |
subtype1 | 2 | 25 |
subtype2 | 2 | 36 |
subtype3 | 1 | 29 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 54 | 34 | 42 |
P value = 0.904 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 102 | 11 | 0.2 - 121.1 (6.2) |
subtype1 | 40 | 5 | 0.2 - 121.1 (5.6) |
subtype2 | 24 | 2 | 0.3 - 72.1 (3.6) |
subtype3 | 38 | 4 | 0.2 - 70.0 (8.1) |
P value = 0.513 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 130 | 65.6 (11.7) |
subtype1 | 54 | 64.8 (12.3) |
subtype2 | 34 | 67.6 (11.5) |
subtype3 | 42 | 64.9 (11.2) |
P value = 0.0423 (Fisher's exact test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 60 | 70 |
subtype1 | 32 | 22 |
subtype2 | 12 | 22 |
subtype3 | 16 | 26 |
P value = 0.255 (Fisher's exact test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 117 | 10 |
subtype1 | 48 | 5 |
subtype2 | 28 | 4 |
subtype3 | 41 | 1 |
P value = 0.2 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 5 | 23 | 91 | 10 |
subtype1 | 4 | 10 | 36 | 4 |
subtype2 | 1 | 4 | 23 | 5 |
subtype3 | 0 | 9 | 32 | 1 |
P value = 0.114 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 64 | 37 | 26 |
subtype1 | 24 | 19 | 10 |
subtype2 | 13 | 10 | 10 |
subtype3 | 27 | 8 | 6 |
P value = 0.0137 (Chi-square test)
nPatients | M0 | M1 | M1A | MX |
---|---|---|---|---|
ALL | 98 | 18 | 2 | 10 |
subtype1 | 39 | 10 | 0 | 5 |
subtype2 | 24 | 7 | 2 | 0 |
subtype3 | 35 | 1 | 0 | 5 |
P value = 0.157 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 21 | 40 | 42 | 19 |
subtype1 | 9 | 14 | 18 | 10 |
subtype2 | 4 | 9 | 10 | 8 |
subtype3 | 8 | 17 | 14 | 1 |
P value = 1 (Fisher's exact test)
nPatients | NO | YES |
---|---|---|
ALL | 5 | 125 |
subtype1 | 2 | 52 |
subtype2 | 1 | 33 |
subtype3 | 2 | 40 |
Cluster Labels | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Number of samples | 6 | 26 | 20 | 42 | 36 |
P value = 0.0032 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 102 | 11 | 0.2 - 121.1 (6.2) |
subtype1 | 4 | 1 | 0.5 - 24.1 (5.2) |
subtype2 | 11 | 1 | 0.9 - 15.8 (1.0) |
subtype3 | 18 | 1 | 0.3 - 72.1 (5.5) |
subtype4 | 38 | 6 | 0.2 - 119.5 (6.6) |
subtype5 | 31 | 2 | 0.2 - 121.1 (8.0) |
P value = 0.0282 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 130 | 65.6 (11.7) |
subtype1 | 6 | 65.2 (11.9) |
subtype2 | 26 | 72.0 (12.0) |
subtype3 | 20 | 62.6 (11.0) |
subtype4 | 42 | 63.4 (10.4) |
subtype5 | 36 | 65.2 (12.2) |
P value = 0.378 (Chi-square test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 60 | 70 |
subtype1 | 4 | 2 |
subtype2 | 15 | 11 |
subtype3 | 8 | 12 |
subtype4 | 20 | 22 |
subtype5 | 13 | 23 |
P value = 0.157 (Chi-square test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 117 | 10 |
subtype1 | 5 | 1 |
subtype2 | 23 | 1 |
subtype3 | 17 | 3 |
subtype4 | 36 | 5 |
subtype5 | 36 | 0 |
P value = 0.402 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 5 | 23 | 91 | 10 |
subtype1 | 1 | 0 | 5 | 0 |
subtype2 | 1 | 3 | 20 | 2 |
subtype3 | 0 | 3 | 13 | 3 |
subtype4 | 2 | 8 | 27 | 5 |
subtype5 | 1 | 9 | 26 | 0 |
P value = 0.0918 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 64 | 37 | 26 |
subtype1 | 2 | 1 | 3 |
subtype2 | 10 | 8 | 8 |
subtype3 | 6 | 8 | 5 |
subtype4 | 22 | 13 | 6 |
subtype5 | 24 | 7 | 4 |
P value = 0.0124 (Chi-square test)
nPatients | M0 | M1 | M1A | MX |
---|---|---|---|---|
ALL | 98 | 18 | 2 | 10 |
subtype1 | 6 | 0 | 0 | 0 |
subtype2 | 18 | 8 | 0 | 0 |
subtype3 | 15 | 1 | 2 | 1 |
subtype4 | 30 | 7 | 0 | 5 |
subtype5 | 29 | 2 | 0 | 4 |
P value = 0.218 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 21 | 40 | 42 | 19 |
subtype1 | 1 | 1 | 4 | 0 |
subtype2 | 4 | 6 | 8 | 6 |
subtype3 | 2 | 3 | 10 | 3 |
subtype4 | 6 | 15 | 11 | 8 |
subtype5 | 8 | 15 | 9 | 2 |
P value = 0.785 (Chi-square test)
nPatients | NO | YES |
---|---|---|
ALL | 5 | 125 |
subtype1 | 0 | 6 |
subtype2 | 0 | 26 |
subtype3 | 1 | 19 |
subtype4 | 2 | 40 |
subtype5 | 2 | 34 |
Cluster Labels | 1 | 2 | 3 | 4 |
---|---|---|---|---|
Number of samples | 18 | 17 | 17 | 20 |
P value = 0.66 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 43 | 4 | 0.9 - 72.1 (10.6) |
subtype1 | 11 | 1 | 1.0 - 52.0 (12.0) |
subtype2 | 9 | 1 | 1.0 - 64.0 (1.0) |
subtype3 | 11 | 2 | 0.9 - 72.1 (12.0) |
subtype4 | 12 | 0 | 0.9 - 61.9 (8.5) |
P value = 0.478 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 72 | 66.8 (10.2) |
subtype1 | 18 | 66.4 (9.5) |
subtype2 | 17 | 65.5 (10.6) |
subtype3 | 17 | 70.1 (9.2) |
subtype4 | 20 | 65.2 (11.4) |
P value = 0.586 (Fisher's exact test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 33 | 39 |
subtype1 | 10 | 8 |
subtype2 | 6 | 11 |
subtype3 | 9 | 8 |
subtype4 | 8 | 12 |
P value = 0.00271 (Fisher's exact test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 60 | 8 |
subtype1 | 17 | 0 |
subtype2 | 14 | 2 |
subtype3 | 17 | 0 |
subtype4 | 12 | 6 |
P value = 0.143 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 5 | 15 | 48 | 4 |
subtype1 | 2 | 3 | 12 | 1 |
subtype2 | 0 | 1 | 14 | 2 |
subtype3 | 0 | 7 | 9 | 1 |
subtype4 | 3 | 4 | 13 | 0 |
P value = 0.702 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 44 | 16 | 12 |
subtype1 | 9 | 6 | 3 |
subtype2 | 9 | 5 | 3 |
subtype3 | 12 | 2 | 3 |
subtype4 | 14 | 3 | 3 |
P value = 0.696 (Fisher's exact test)
nPatients | M0 | M1 |
---|---|---|
ALL | 61 | 11 |
subtype1 | 16 | 2 |
subtype2 | 13 | 4 |
subtype3 | 14 | 3 |
subtype4 | 18 | 2 |
P value = 0.562 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 18 | 25 | 18 | 10 |
subtype1 | 5 | 4 | 7 | 2 |
subtype2 | 1 | 8 | 4 | 3 |
subtype3 | 5 | 6 | 3 | 3 |
subtype4 | 7 | 7 | 4 | 2 |
P value = 0.472 (Fisher's exact test)
nPatients | NO | YES |
---|---|---|
ALL | 1 | 71 |
subtype1 | 0 | 18 |
subtype2 | 1 | 16 |
subtype3 | 0 | 17 |
subtype4 | 0 | 20 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 17 | 24 | 31 |
P value = 0.382 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 43 | 4 | 0.9 - 72.1 (10.6) |
subtype1 | 11 | 1 | 1.0 - 52.0 (10.6) |
subtype2 | 13 | 0 | 0.9 - 61.9 (12.7) |
subtype3 | 19 | 3 | 0.9 - 72.1 (1.9) |
P value = 0.283 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 72 | 66.8 (10.2) |
subtype1 | 17 | 65.1 (8.0) |
subtype2 | 24 | 65.0 (12.5) |
subtype3 | 31 | 69.0 (9.3) |
P value = 0.87 (Fisher's exact test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 33 | 39 |
subtype1 | 7 | 10 |
subtype2 | 12 | 12 |
subtype3 | 14 | 17 |
P value = 2.93e-05 (Fisher's exact test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 60 | 8 |
subtype1 | 16 | 0 |
subtype2 | 13 | 8 |
subtype3 | 31 | 0 |
P value = 0.709 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 5 | 15 | 48 | 4 |
subtype1 | 2 | 3 | 11 | 1 |
subtype2 | 2 | 5 | 17 | 0 |
subtype3 | 1 | 7 | 20 | 3 |
P value = 0.761 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 44 | 16 | 12 |
subtype1 | 9 | 4 | 4 |
subtype2 | 17 | 4 | 3 |
subtype3 | 18 | 8 | 5 |
P value = 0.589 (Fisher's exact test)
nPatients | M0 | M1 |
---|---|---|
ALL | 61 | 11 |
subtype1 | 14 | 3 |
subtype2 | 22 | 2 |
subtype3 | 25 | 6 |
P value = 0.842 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 18 | 25 | 18 | 10 |
subtype1 | 5 | 4 | 5 | 3 |
subtype2 | 7 | 10 | 5 | 2 |
subtype3 | 6 | 11 | 8 | 5 |
P value = 0.569 (Fisher's exact test)
nPatients | NO | YES |
---|---|---|
ALL | 1 | 71 |
subtype1 | 0 | 17 |
subtype2 | 1 | 23 |
subtype3 | 0 | 31 |
Cluster Labels | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Number of samples | 18 | 42 | 17 | 10 | 56 |
P value = 0.314 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 106 | 10 | 0.2 - 121.1 (7.0) |
subtype1 | 16 | 3 | 0.3 - 121.1 (8.7) |
subtype2 | 38 | 5 | 0.5 - 60.0 (7.3) |
subtype3 | 15 | 0 | 0.5 - 119.5 (6.0) |
subtype4 | 10 | 0 | 0.2 - 72.1 (1.5) |
subtype5 | 27 | 2 | 0.9 - 70.0 (1.9) |
P value = 0.892 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 65.4 (11.5) |
subtype1 | 18 | 65.2 (9.4) |
subtype2 | 42 | 64.1 (12.6) |
subtype3 | 17 | 65.3 (14.5) |
subtype4 | 10 | 64.8 (7.4) |
subtype5 | 56 | 66.6 (11.1) |
P value = 0.461 (Chi-square test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 66 | 77 |
subtype1 | 8 | 10 |
subtype2 | 18 | 24 |
subtype3 | 11 | 6 |
subtype4 | 3 | 7 |
subtype5 | 26 | 30 |
P value = 0.313 (Chi-square test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 127 | 10 |
subtype1 | 15 | 2 |
subtype2 | 40 | 1 |
subtype3 | 17 | 0 |
subtype4 | 9 | 1 |
subtype5 | 46 | 6 |
P value = 0.251 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 9 | 26 | 97 | 10 |
subtype1 | 0 | 0 | 14 | 3 |
subtype2 | 2 | 9 | 29 | 2 |
subtype3 | 3 | 3 | 9 | 2 |
subtype4 | 0 | 2 | 8 | 0 |
subtype5 | 4 | 12 | 37 | 3 |
P value = 0.0172 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 74 | 38 | 28 |
subtype1 | 5 | 4 | 7 |
subtype2 | 16 | 19 | 7 |
subtype3 | 11 | 4 | 2 |
subtype4 | 6 | 1 | 2 |
subtype5 | 36 | 10 | 10 |
P value = 0.0461 (Chi-square test)
nPatients | M0 | M1 | M1A | MX |
---|---|---|---|---|
ALL | 107 | 18 | 2 | 14 |
subtype1 | 11 | 2 | 1 | 3 |
subtype2 | 28 | 4 | 0 | 9 |
subtype3 | 13 | 2 | 1 | 1 |
subtype4 | 7 | 2 | 0 | 1 |
subtype5 | 48 | 8 | 0 | 0 |
P value = 0.117 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 28 | 44 | 43 | 20 |
subtype1 | 0 | 5 | 6 | 3 |
subtype2 | 6 | 9 | 20 | 5 |
subtype3 | 6 | 5 | 3 | 3 |
subtype4 | 1 | 4 | 2 | 2 |
subtype5 | 15 | 21 | 12 | 7 |
P value = 0.283 (Chi-square test)
nPatients | NO | YES |
---|---|---|
ALL | 6 | 137 |
subtype1 | 2 | 16 |
subtype2 | 3 | 39 |
subtype3 | 0 | 17 |
subtype4 | 0 | 10 |
subtype5 | 1 | 55 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 20 | 64 | 59 |
P value = 0.774 (logrank test)
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 106 | 10 | 0.2 - 121.1 (7.0) |
subtype1 | 18 | 1 | 0.2 - 64.0 (3.4) |
subtype2 | 35 | 3 | 0.9 - 72.1 (10.4) |
subtype3 | 53 | 6 | 0.2 - 121.1 (7.4) |
P value = 0.582 (ANOVA)
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 65.4 (11.5) |
subtype1 | 20 | 62.9 (13.5) |
subtype2 | 64 | 65.8 (10.4) |
subtype3 | 59 | 65.8 (12.0) |
P value = 0.973 (Fisher's exact test)
nPatients | FEMALE | MALE |
---|---|---|
ALL | 66 | 77 |
subtype1 | 9 | 11 |
subtype2 | 29 | 35 |
subtype3 | 28 | 31 |
P value = 0.037 (Fisher's exact test)
nPatients | RECTAL ADENOCARCINOMA | RECTAL MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 127 | 10 |
subtype1 | 19 | 1 |
subtype2 | 52 | 8 |
subtype3 | 56 | 1 |
P value = 0.726 (Chi-square test)
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 9 | 26 | 97 | 10 |
subtype1 | 1 | 2 | 16 | 1 |
subtype2 | 5 | 14 | 42 | 3 |
subtype3 | 3 | 10 | 39 | 6 |
P value = 0.244 (Chi-square test)
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 74 | 38 | 28 |
subtype1 | 7 | 9 | 3 |
subtype2 | 38 | 14 | 12 |
subtype3 | 29 | 15 | 13 |
P value = 0.000442 (Chi-square test)
nPatients | M0 | M1 | M1A | MX |
---|---|---|---|---|
ALL | 107 | 18 | 2 | 14 |
subtype1 | 13 | 5 | 0 | 2 |
subtype2 | 53 | 11 | 0 | 0 |
subtype3 | 41 | 2 | 2 | 12 |
P value = 0.361 (Chi-square test)
nPatients | I | II | III | IV |
---|---|---|---|---|
ALL | 28 | 44 | 43 | 20 |
subtype1 | 2 | 5 | 7 | 5 |
subtype2 | 17 | 20 | 16 | 9 |
subtype3 | 9 | 19 | 20 | 6 |
P value = 0.298 (Fisher's exact test)
nPatients | NO | YES |
---|---|---|
ALL | 6 | 137 |
subtype1 | 1 | 19 |
subtype2 | 1 | 63 |
subtype3 | 4 | 55 |
-
Cluster data file = READ-TP.mergedcluster.txt
-
Clinical data file = READ-TP.clin.merged.picked.txt
-
Number of patients = 166
-
Number of clustering approaches = 10
-
Number of selected clinical features = 9
-
Exclude small clusters that include fewer than K patients, K = 3
consensus non-negative matrix factorization clustering approach (Brunet et al. 2004)
Resampling-based clustering method (Monti et al. 2003)
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, one-way analysis of variance (Howell 2002) was applied to compare the clinical values between tumor subtypes using 'anova' function in R
For binary clinical features, two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multi-class clinical features (nominal or ordinal), Chi-square tests (Greenwood and Nikulin 1996) were used to estimate the P values using the 'chisq.test' function in R
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.